Daknos MR 250mg/50mg/325mg Tablet
By Daknos MR
Rx
10 Tablet in a Strip

Composition
Chlorzoxazone(250mg) + Diclofenac(50mg) + Paracetamol(325mg)

Manufacturer - Cuber Lifesciences
SCF 600, 1st & 2nd Floor, Manimajra Chandigarh -160101,India

Expires on or after
October, 2025

liver
Caution should be taken when using Daknos MR 250mg/50mg/325mg Tablet in patients with liver disease. Limited information is available regarding its safety in such cases. It is advised to consult with your doctor before using this medication to ensure proper guidance and monitoring.

kidney
Limited information is available on the use of Daknos MR 250mg/50mg/325mg Tablet in patients with kidney disease. Please consult your doctor.

alcohol
It is not known if it is safe to drink alcohol while taking Daknos MR 250mg/50mg/325mg Tablet. Consult your doctor for guidance.

driving
It is not confirmed if taking Daknos MR 250mg/50mg/325mg Tablet affects driving abilities. If symptoms impair focus and reaction, avoid driving while using this medication.

pregnancy
Information about the safety of Daknos MR 250mg/50mg/325mg Tablet during pregnancy is not known. It is recommended to consult your doctor before using this medicine while pregnant.

breastfeeding
It is better to consult your doctor before using Daknos MR 250mg/50mg/325mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹45
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024